Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Tiaprofenic acid 200 mg, 300mg Tablets Apotex Inc., Weston, Ontario, Canada Apo-Tiaprofenic Cyproterone acetate 50 mg Tablet Generics (UK) Limited, Potters Bar, Hertfordshire, United Kingdom Cypro 50 Potassium phosphate dibasic 2 mmol/mL in 20 mL Solution for infusion (ampoule) Biomed Laboratories Limited, Point Chevalier, Auckland Dibasic Potassium Phosphate Pholcodine 3 mg/mL in 200 mL Linctus 3M Pharmaceuticals Pty Limited, Thornleigh, New South Wales, Australia Duro-Tuss Forte Pholcodine 1 mg/mL in 200 mL Linctus 3M Pharmaceuticals Pty Limited, Thornleigh, New South Wales, Australia Duro-Tuss Regular Influenza virus A/Beijing/32/92 15 mcg, influenza virus A/Singapore/6/86 15 mcg, influenza virus B/Panama/45/90 15 mcg Vaccine, pre-filled syringe Sachsisches Serumwerk GmbH, Dresden, Germany and SmithKline Biologicals, Rixensart, Belgium Fluarix Influenza virus A/Beijing/32/92 15 mcg, influenza virus A/Singapore/6/86 15 mcg, influenza virus B/Panama/45/90 15 mcg Vaccine, single dose vial Sachsisches Serumwerk GmbH, Dresden, Germany and SmithKline Biologicals, Rixensart, Belgium Fluarix Haloperidol decanoate equivalent to 50 mg/mL haloperidol in 1 mL, 3 mL Depot injection David Bull Laboratories Limited, Mulgrave North, Victoria, Australia Halperidol Decanoate Oily Injection Hydrochlorothiazide 12.5 mg, Losartan potassium 50 mg Tablet Du Pont Merck Pharmaceuticals Co., Garden City, New York, United States of America and Merck Sharp & Dohme Limited, Cramlington, Northumberland, England Hyzaar Dextromethorphan hydrobromide 1.5 mg/mL in 100 mL, 200 mL Solution, Oral Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Robitussin Cough Control Syrup Desflurance 100% in 240 mL Liquid, volatile for inhalation Ohmeda Caribe Inc., Guayama, Puerto Rico Suprane Dated this 8th day of December 1995. KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.